Biotech Acquisition Company Cl A (BIOT)
Biotech Acquisition Company Cl A (BIOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2006 | |
| Cost of Goods | 1,570 | 5 | N/A |
| Gross Profit | -1,570 | -5 | N/A |
| Operating Expenses | 570 | 5 | 0 |
| Operating Income | -1,570 | -5 | N/A |
| Other Income | -5,294 | 0 | 0 |
| Pre-tax Income | -6,865 | -5 | 0 |
| Net Income Continuous | -6,865 | -5 | N/A |
| Net Income | $-6,865 | $-5 | $N/A |
| EPS Basic Total Ops | -0.25 | 0.00 | N/A |
| EPS Basic Continuous Ops | -1.21 | 0.00 | N/A |
| EPS Diluted Total Ops | -0.25 | 0.00 | N/A |
| EPS Diluted Continuous Ops | -1.21 | 0.00 | N/A |
| EBITDA(a) | $-1,570 | $-5 | $N/A |